홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

(2S)-6-[[(2S)-3-(1H-indol-3-yl)-2-[(4-nitrophenyl)sulfonylamino]propanoyl]amino]-2-[isobutyl(p-tolylsulfonyl)amino]hexanoic acid → (2S)-6-[[(2S)-2-[(4-aminophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoyl]amino]-2-[isobutyl(p-tolylsulfonyl)amino]hexanoic acid

HRID 431311
노트
인쇄 미리보기

반응식

HRID 431311 반응식
Cl.C(N(S(C1C=CC(C)=CC=1)(=O)=O)[C@H](C(O)=O)CCCCN)C(C)C.[N+](C1C=CC(S(N[C@H](C(O)=O)CC2C3C(=CC=CC=3)NC=2)(=O)=O)=CC=1)([O-])=O.[CH3:53][C:54]1[CH:59]=[CH:58][C:57]([S:60]([N:63]([C@H:68]([C:100]([OH:102])=[O:101])[CH2:69][CH2:70][CH2:71][CH2:72][NH:73][C:74]([C@@H:76]([NH:87][S:88]([C:91]2[CH:96]=[CH:95][C:94]([N+:97]([O-])=O)=[CH:93][CH:92]=2)(=[O:90])=[O:89])[CH2:77][C:78]2[C:86]3[C:81](=[CH:82][CH:83]=[CH:84][CH:85]=3)[NH:80][CH:79]=2)=[O:75])[CH2:64][CH:65]([CH3:67])[CH3:66])(=[O:62])=[O:61])=[CH:56][CH:55]=1>>[CH3:53][C:54]1[CH:55]=[CH:56][C:57]([S:60]([N:63]([C@H:68]([C:100]([OH:102])=[O:101])[CH2:69][CH2:70][CH2:71][CH2:72][NH:73][C:74]([C@@H:76]([NH:87][S:88]([C:91]2[CH:92]=[CH:93][C:94]([NH2:97])=[CH:95][CH:96]=2)(=[O:89])=[O:90])[CH2:77][C:78]2[C:86]3[C:81](=[CH:82][CH:83]=[CH:84][CH:85]=3)[NH:80][CH:79]=2)=[O:75])[CH2:64][CH:65]([CH3:67])[CH3:66])(=[O:61])=[O:62])=[CH:58][CH:59]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 508531(2S)-6-[[(2S)-3-(1H-indol-3-yl)-2-[(4-nitrophenyl)sulfonylamino]propanoyl]amino]-2-[isobutyl(p-tolylsulfonyl)amino]hexanoic acidHCID 1572095Nalpha(4-nitrobenzenesulfonyl)-L-tryptophanHCID 23552859Nalpha-isobutyl-Nalpha-(4-methylbenzenesulfonyl)-L-lysine hydrochloride

생성물 1

HCID 508536(2S)-6-[[(2S)-2-[(4-aminophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoyl]amino]-2-[isobutyl(p-tolylsulfonyl)amino]hexanoic acid

실험 절차

The title compound was prepared from Nα-isobutyl-Nα-(4-methylbenzenesulfonyl)-L-lysine hydrochloride (200 mg, 0.59 mmol, example 1, step E) as described in general procedure Bc using Nα-(4-nitrobenzenesulfonyl)-L-tryptophan (300 mg, 0.75 mmol) prepared in step A of example 5. The intermediate, Nα-isobutyl-Nα-(4-methylbenzenesulfonyl)-Nε-[N′α-(4-nitrobenzenesulfonyl)-L-tryptophanyl]-L-lysine, was reduced following the conditions of general procedure E. The final product was purified by preparative HPLC to yield 266 mg (58%) of the desired material.

후처리

  1. customThe final product was purified by preparative HPLC

출처 및 근거

ORD 기록
ord-bbe0ec4fbee3478bbc3350f6888a0698
출처 데이터셋
uspto-grants-2003_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06656965B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트